122 related articles for article (PubMed ID: 38775901)
21. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G
Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315
[TBL] [Abstract][Full Text] [Related]
22. Predictors of Virological Failure after Adherence-Enhancement Counseling among First-Line Adults Living with HIV/AIDS in Kombolcha Town, Northeast Ethiopia.
Bisetegn G; Arefaynie M; Mohammed A; Fentaw Z; Muche A; Dewau R; Seid Y
HIV AIDS (Auckl); 2021; 13():91-97. PubMed ID: 33531843
[TBL] [Abstract][Full Text] [Related]
23. Attrition and Its Predictors Among Adults Receiving First-Line Antiretroviral Therapy in Woldia Town Public Health Facilities, Northeast Ethiopia: A Retrospective Cohort Study.
Dejen D; Jara D; Yeshanew F; Fentaw Z; Mengie Feleke T; Girmaw F; Wagaye B
HIV AIDS (Auckl); 2021; 13():445-454. PubMed ID: 33907472
[TBL] [Abstract][Full Text] [Related]
24. Predictors of Survival Time Among HIV-Infected Adults After Initiating Anti-Retroviral Therapy in Kombolcha Town: A 5-Year Retrospective Cohort Study.
Siraj M; Gedamu S; Tegegne B
HIV AIDS (Auckl); 2022; 14():181-194. PubMed ID: 35464618
[TBL] [Abstract][Full Text] [Related]
25. Effect and implementation experience of intensive adherence counseling in a public HIV care center in Uganda: a mixed-methods study.
Lukyamuzi Z; Etajak S; Katairo T; Mukunya D; Tetui M; Ssenyonjo A; Wanyenze RK
BMC Infect Dis; 2021 Nov; 21(1):1168. PubMed ID: 34798852
[TBL] [Abstract][Full Text] [Related]
26. Magnitude of Viral Load Suppression and Associated Factors among Clients on Antiretroviral Therapy in Public Hospitals of Hawassa City Administration, Ethiopia.
Anito AA; Lenjebo TL; Woticha E; Solomon F
HIV AIDS (Auckl); 2022; 14():529-538. PubMed ID: 36425750
[TBL] [Abstract][Full Text] [Related]
27. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
[TBL] [Abstract][Full Text] [Related]
28. Multivariate analysis of covariates of adherence among HIV-positive mothers with low viral suppression.
Nsubuga-Nyombi T; Sensalire S; Karamagi E; Aloyo J; Byabagambi J; Rahimzai M; Nabitaka LK; Calnan J
AIDS Res Ther; 2018 Mar; 15(1):9. PubMed ID: 29604955
[TBL] [Abstract][Full Text] [Related]
29. Joint Modeling of Incidence of Unfavorable Outcomes and Change in Viral Load Over Time Among Adult HIV/AIDS Patients on Second-Line Anti-Retroviral Therapy, in Selected Public Hospitals of Addis Ababa, Ethiopia.
Zakaria HF; Ayele TA; Kebede SA; Jaldo MM; Lajore BA
HIV AIDS (Auckl); 2022; 14():341-354. PubMed ID: 35923902
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
31. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study.
Yihun BA; Kibret GD; Leshargie CT
PLoS One; 2019; 14(5):e0215300. PubMed ID: 31042743
[TBL] [Abstract][Full Text] [Related]
32. Incidence and predictors of loss to follow-up among adult patients receiving antiretroviral therapy in Central Ethiopia: a multi-center retrospective cohort study.
Anulo A; Girma A; Tesfaye G; Asefa F; Cheru A; Lonsako AA
Front Public Health; 2024; 12():1374515. PubMed ID: 38544723
[TBL] [Abstract][Full Text] [Related]
33. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
34. Rate of Viral Re-Suppression and Retention to Care Among PLHIV on Second-Line Antiretroviral Therapy at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia: A Retrospective Cohort Study.
Wedajo S; Degu G; Deribew A; Ambaw F
HIV AIDS (Auckl); 2021; 13():877-887. PubMed ID: 34526824
[TBL] [Abstract][Full Text] [Related]
35. Effect of Phone-Based Enhanced Adherence Counseling (EAC) Among Virally Unsuppressed Key Population (KP).
Ekejiuba C; Timbri T; Chizoba AF; Dalley O; Gurjar U; Ekejiuba GT; Enejoh V; Olayiwola O; Oko JO; Effiong A; Ikechukwu U; Udegbunam C; Oji L; Okobi OE
Cureus; 2023 Apr; 15(4):e38005. PubMed ID: 37223168
[TBL] [Abstract][Full Text] [Related]
36. Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar, Ethiopia.
Shiferaw MB; Endalamaw D; Hussien M; Agegne M; Amare D; Estifanos F; Temesgen D
BMC Infect Dis; 2019 May; 19(1):419. PubMed ID: 31088496
[TBL] [Abstract][Full Text] [Related]
37. Virologic failure in HIV-positive adolescents with perfect adherence in Uganda: a cross-sectional study.
Natukunda J; Kirabira P; Ong KIC; Shibanuma A; Jimba M
Trop Med Health; 2019; 47():8. PubMed ID: 30679930
[TBL] [Abstract][Full Text] [Related]
38. Dolutegravir based therapy showed CD4
Gebremedhin T; Aynalem M; Adem M; Geremew D; Aleka Y; Kiflie A
Sci Rep; 2024 Feb; 14(1):3297. PubMed ID: 38331983
[TBL] [Abstract][Full Text] [Related]
39. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
[TBL] [Abstract][Full Text] [Related]
40. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
